SECOND AMENDMENT TO CREDIT AGREEMENTCredit Agreement • November 9th, 2015 • Teligent, Inc. • Biological products, (no disgnostic substances) • New York
THIS SECOND AMENDMENT TO CREDIT AGREEMENT (this “Agreement”) is entered into as of August 14, 2015 by and among IGI Laboratories, Inc., a Delaware corporation (“IGI”), Igen Inc., a Delaware corporation (“Igen”), IGI Labs, Inc., a Delaware corporation (“IGI Labs”) (IGI, Igen and IGI Labs are sometimes referred to herein collectively as the “Borrowers” and individually as a “Borrower”), General Electric Capital Corporation, as Agent, and the Lenders signatory hereto.
ASSET PURCHASE AGREEMENT among CONCORDIA PHARMACEUTICALS INC., S.À.R.L., BARBADOS BRANCH, TELIGENT JERSEY LIMITED and IGI LABORATORIES, INC. DATED AS OF OCTOBER 5, 2015Asset Purchase Agreement • November 9th, 2015 • Teligent, Inc. • Biological products, (no disgnostic substances) • Delaware
This Asset Purchase Agreement is made and entered into as of the 5th day of October 2015, by and between Concordia Pharmaceuticals Inc., S.à.r.l., Barbados Branch, the Barbados branch of Concordia Pharmaceuticals Inc., a société à responsabilité limitée (private limited liability company) duly organized and validly existing under the laws of the Grand-Duchy of Luxembourg, with a share capital of USD 5,000,000, having its registered office at 8-10 Avenue de la Gare – L-2610 Luxembourg, Grand-Duchy of Luxembourg and in the process of registration with the Registre de Commerce et des Sociétés, Luxembourg (Luxembourg Trade and Companies Register) (formerly known as and successor-in-interest to Concordia Pharmaceuticals Inc., an international business company organized under the laws of Barbados) (“Seller”), on the one hand, and IGI Laboratories, Inc., a corporation organized under the laws of Delaware (“IGI Purchaser”), and Teligent Jersey Limited, a company incorporated in Jersey with reg
THIRD AMENDMENT TO CREDIT AGREEMENTCredit Agreement • November 9th, 2015 • Teligent, Inc. • Biological products, (no disgnostic substances) • New York
THIS THIRD AMENDMENT TO CREDIT AGREEMENT (this “Agreement”) is entered into as of September 16, 2015 by and among IGI Laboratories, Inc., a Delaware corporation (“IGI”), Igen Inc., a Delaware corporation (“Igen”), IGI Labs, Inc., a Delaware corporation (“IGI Labs”) (IGI, Igen and IGI Labs are sometimes referred to herein collectively as the “Borrowers” and individually as a “Borrower”), General Electric Capital Corporation, as Agent, and the Lenders signatory hereto.
